Cargando…
COVID-19 vaccine type and Guillain-Barré syndrome: Comment
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294747/ https://www.ncbi.nlm.nih.gov/pubmed/37096296 http://dx.doi.org/10.1080/21645515.2023.2200355 |
| _version_ | 1785063256728010752 |
|---|---|
| author | Kleebayoon, Amnuay Wiwanitkit, Viroj |
| author_facet | Kleebayoon, Amnuay Wiwanitkit, Viroj |
| author_sort | Kleebayoon, Amnuay |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10294747 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Taylor & Francis |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102947472023-06-28 COVID-19 vaccine type and Guillain-Barré syndrome: Comment Kleebayoon, Amnuay Wiwanitkit, Viroj Hum Vaccin Immunother Coronavirus Taylor & Francis 2023-04-24 /pmc/articles/PMC10294747/ /pubmed/37096296 http://dx.doi.org/10.1080/21645515.2023.2200355 Text en © 2023 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
| spellingShingle | Coronavirus Kleebayoon, Amnuay Wiwanitkit, Viroj COVID-19 vaccine type and Guillain-Barré syndrome: Comment |
| title | COVID-19 vaccine type and Guillain-Barré syndrome: Comment |
| title_full | COVID-19 vaccine type and Guillain-Barré syndrome: Comment |
| title_fullStr | COVID-19 vaccine type and Guillain-Barré syndrome: Comment |
| title_full_unstemmed | COVID-19 vaccine type and Guillain-Barré syndrome: Comment |
| title_short | COVID-19 vaccine type and Guillain-Barré syndrome: Comment |
| title_sort | covid-19 vaccine type and guillain-barré syndrome: comment |
| topic | Coronavirus |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294747/ https://www.ncbi.nlm.nih.gov/pubmed/37096296 http://dx.doi.org/10.1080/21645515.2023.2200355 |
| work_keys_str_mv | AT kleebayoonamnuay covid19vaccinetypeandguillainbarresyndromecomment AT wiwanitkitviroj covid19vaccinetypeandguillainbarresyndromecomment |